ESC Premium Access

Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects? – discussion.

Congress Presentation

4 more presentations in this session

Prophylactic ablation of preexcitation: when and for whom?

Speaker: Professor J. Brugada Terradellas (Barcelona, ES)

Thumbnail

Treatment of asymptomatic PVCs: when should it be attempted?

Speaker: Professor T. Reichlin (Bern, CH)

Thumbnail

What is the optimal treatment of asymptomatic patients with primary electrical syndromes?

Speaker: Professor K. Haugaa (Stockholm, SE)

Thumbnail

Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects? - Chat Moderator.

Thumbnail

Access the full session

Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects?

Speakers: Professor J. Brugada Terradellas, Professor T. Reichlin, Professor K. Haugaa
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

EHRA Premium Access

Physiological pacing.

3 April 2022

EHRA Premium Access

Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping

3 April 2022

ACVC Premium Access

Cardiogenic shock: state of the art 2022 - discussion.

19 March 2022

ESC 365 is supported by

logo Novo Nordisk